Test your knowledge on measurable residual disease with time-limited Venetoclax-based regimens

Which of the following is currently the standard threshold for MRD detection for the majority of clinical trials in CLL? 
10-4 
10-5 
10-6 
10-8 
Discordance between uMRD as detected by PB vs. BM could be due to location of the BM aspirate sample, timing of the BM aspirate, the patient’s treatment status, and/or the compartmentalized nature of CLL. 
True
False
Testing MRD at the level of 10-4 assesses for presence of CLL cells at which of the following thresholds: 
1 in 100 
1 in 1,000 
1 in 10,000 
1 in 100,000 
The estimated 5 year PFS for patients with CLL treated with venetoclax in the frontline setting regardless of EOT MRD status is approximately:  
50% 
60% 
70% 
80% 
{"name":"Test your knowledge on measurable residual disease with time-limited Venetoclax-based regimens", "url":"https://www.quiz-maker.com/QWMCS0P1K","txt":"Which of the following is currently the standard threshold for MRD detection for the majority of clinical trials in CLL?, Discordance between uMRD as detected by PB vs. BM could be due to location of the BM aspirate sample, timing of the BM aspirate, the patient’s treatment status, and\/or the compartmentalized nature of CLL., Testing MRD at the level of 10-4 assesses for presence of CLL cells at which of the following thresholds:","img":"https://www.quiz-maker.com/3012/images/ogquiz.png"}
Tools: Poll Maker | Quiz Maker | Super Surveys